National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05DB	DIANEAL PD4 3.86% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 38.6g/l		Injectable solution	1,111,506 L.L
B05DB	DIANEAL PD4 CYCLER 3.86% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 38.6g/l		Injectable solution	1,150,329 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 300mg	300mg	Injectable solution	123,001,362 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 300mg	300mg	Injectable solution	123,001,362 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 200mg	200mg	Injectable solution	123,001,362 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 200mg	200mg	Injectable solution	123,001,362 L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 1800mg	1800mg	Injectable solution	494,909,963 L.L
A11CC05	DIBASE	G	Vitamin D3 - 100,000IU/ml	100,000IU/ml	Injectable solution	354,774 L.L
H02AB02	DEXAMED	G	Dexamethasone - 8mg/2ml	8mg/2ml	Injectable solution	2,998,113 L.L
H02AB02	DEXAMED	G	Dexamethasone - 8mg/2ml	8mg/2ml	Injectable solution	338,648 L.L
H02AB02	DEXAMEDIS FORT	G	Dexamethasone Phosphate - 8mg/2ml	8mg/2ml	Injectable solution	43,003 L.L
H02AB02	DEXAMETHASONE SODIUM PHOSPHATE USP - EIPICO	G	Dexamethasone (sodium phosphate) - 8mg/2ml	8mg/2ml	Injectable solution	185,450 L.L
H02AB02	DEXASINA	G	Dexamethasone Phosphate - 8mg/2ml	8mg/2ml	Injectable solution	3,471,145 L.L
H02AB02	DEXAMETHASON-PANPHARMA	G	Dexamethasone - 5mg/1ml	5mg/1ml	Injectable solution	368,213 L.L
H02AB02	DEXAMETHASONE MEDIS	G	Dexamethasone Phosphate - 4mg/1ml	4mg/1ml	Injectable solution	1,154,361 L.L
L01CD02	DOCETAXEL EBEWE	G	Docetaxel - 80mg/8ml	80mg/8ml	Injectable solution	19,518,281 L.L
L01CD02	DOCETAXEL EBEWE	G	Docetaxel - 20mg/2ml	20mg/2ml	Injectable solution	5,313,553 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.9%	G	Sodium chloride - 0.9g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	189,262 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.9%	G	Sodium chloride - 0.9g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	182,720 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.9%	G	Sodium chloride - 0.9g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	207,894 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.9%	G	Sodium chloride - 0.9g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	198,578 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.9%	G	Sodium chloride - 0.9g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	226,036 L.L
B05BB02	DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%		Injectable solution	194,211 L.L
B05BB02	DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%		Injectable solution	180,421 L.L
B05BB02	DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%		Injectable solution	186,167 L.L
L01DB01	DOXO-CELL	G	Doxorubicin HCl - 50mg/25ml	50mg/25ml	Injectable solution	1,794,030 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.45%	G	Sodium chloride - 0.45g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	205,933 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.45%	G	Sodium chloride - 0.45g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	182,720 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.45%	G	Sodium chloride - 0.45g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	217,210 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.45%	G	Sodium chloride - 0.45g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	240,255 L.L

National Cancer Registry (NCR)